147 related articles for article (PubMed ID: 35789495)
1. The involvement of a chemokine receptor antagonist CTCE-9908 and kynurenine metabolites in cancer development.
Nkandeu DS; Basson C; Joubert AM; Serem JC; Bipath P; Nyakudya T; Hlophe Y
Cell Biochem Funct; 2022 Aug; 40(6):608-622. PubMed ID: 35789495
[TBL] [Abstract][Full Text] [Related]
2. In vitro effects and mathematical modelling of CTCE-9908 (a chemokine receptor 4 antagonist) on melanoma cell survival.
Basson C; Phiri AE; Gandhi M; Anguelov R; Serem JC; Bipath P; Hlophe YN
Clin Exp Pharmacol Physiol; 2024 Jun; 51(6):e13865. PubMed ID: 38692577
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases.
Kim SY; Lee CH; Midura BV; Yeung C; Mendoza A; Hong SH; Ren L; Wong D; Korz W; Merzouk A; Salari H; Zhang H; Hwang ST; Khanna C; Helman LJ
Clin Exp Metastasis; 2008; 25(3):201-11. PubMed ID: 18071913
[TBL] [Abstract][Full Text] [Related]
4. CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model.
Hassan S; Buchanan M; Jahan K; Aguilar-Mahecha A; Gaboury L; Muller WJ; Alsawafi Y; Mourskaia AA; Siegel PM; Salvucci O; Basik M
Int J Cancer; 2011 Jul; 129(1):225-32. PubMed ID: 20830712
[TBL] [Abstract][Full Text] [Related]
5. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
[TBL] [Abstract][Full Text] [Related]
6. The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor.
Pelus LM; Bian H; Fukuda S; Wong D; Merzouk A; Salari H
Exp Hematol; 2005 Mar; 33(3):295-307. PubMed ID: 15730853
[TBL] [Abstract][Full Text] [Related]
7. Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma.
Guo L; Cui ZM; Zhang J; Huang Y
Chin J Cancer; 2011 May; 30(5):336-43. PubMed ID: 21527066
[TBL] [Abstract][Full Text] [Related]
8. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells.
Murakami T; Maki W; Cardones AR; Fang H; Tun Kyi A; Nestle FO; Hwang ST
Cancer Res; 2002 Dec; 62(24):7328-34. PubMed ID: 12499276
[TBL] [Abstract][Full Text] [Related]
9. The CXCR4/CXCL12 axis in cutaneous malignancies with an emphasis on melanoma.
Mitchell B; Mahalingam M
Histol Histopathol; 2014 Dec; 29(12):1539-46. PubMed ID: 24879309
[TBL] [Abstract][Full Text] [Related]
10. CXC chemokine ligand 12 (stromal cell-derived factor 1 alpha) and CXCR4-dependent migration of CTLs toward melanoma cells in organotypic culture.
Zhang T; Somasundaram R; Berencsi K; Caputo L; Rani P; Guerry D; Furth E; Rollins BJ; Putt M; Gimotty P; Swoboda R; Herlyn M; Herlyn D
J Immunol; 2005 May; 174(9):5856-63. PubMed ID: 15843590
[TBL] [Abstract][Full Text] [Related]
11. Effective inhibition of metastases and primary tumor growth with CTCE-9908 in esophageal cancer.
Drenckhan A; Kurschat N; Dohrmann T; Raabe N; Koenig AM; Reichelt U; Kaifi JT; Izbicki JR; Gros SJ
J Surg Res; 2013 Jun; 182(2):250-6. PubMed ID: 23117118
[TBL] [Abstract][Full Text] [Related]
12. A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer.
Huang EH; Singh B; Cristofanilli M; Gelovani J; Wei C; Vincent L; Cook KR; Lucci A
J Surg Res; 2009 Aug; 155(2):231-6. PubMed ID: 19482312
[TBL] [Abstract][Full Text] [Related]
13. Preferential involvement of CX chemokine receptor 4 and CX chemokine ligand 12 in T-cell migration toward melanoma cells.
Zhang T; Somasundaram R; Berking C; Caputo L; Van Belle P; Elder D; Czerniecki B; Hotz S; Schuchter L; Spitz FR; Berencsi K; Rani P; Marincola F; Qiu R; Herlyn D
Cancer Biol Ther; 2006 Oct; 5(10):1304-12. PubMed ID: 16929176
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma.
McConnell AT; Ellis R; Pathy B; Plummer R; Lovat PE; O'Boyle G
Br J Dermatol; 2016 Dec; 175(6):1210-1220. PubMed ID: 27167239
[TBL] [Abstract][Full Text] [Related]
15. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
[TBL] [Abstract][Full Text] [Related]
16. An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells.
Kwong J; Kulbe H; Wong D; Chakravarty P; Balkwill F
Mol Cancer Ther; 2009 Jul; 8(7):1893-905. PubMed ID: 19567818
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of CXC chemokine receptor 4-CXC chemokine ligand 12 axis ininvasive breast carcinoma: A potent biomarker predicting lymph node metastasis.
Dayer R; Babashah S; Jamshidi S; Sadeghizadeh M
J Cancer Res Ther; 2018; 14(2):345-350. PubMed ID: 29516917
[TBL] [Abstract][Full Text] [Related]
18. The role of CXC chemokine ligand (CXCL)12-CXC chemokine receptor (CXCR)4 signalling in the migration of neural stem cells towards a brain tumour.
van der Meulen AA; Biber K; Lukovac S; Balasubramaniyan V; den Dunnen WF; Boddeke HW; Mooij JJ
Neuropathol Appl Neurobiol; 2009 Dec; 35(6):579-91. PubMed ID: 19627512
[TBL] [Abstract][Full Text] [Related]
19. Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis.
Wong D; Kandagatla P; Korz W; Chinni SR
BMC Urol; 2014 Jan; 14():12. PubMed ID: 24472670
[TBL] [Abstract][Full Text] [Related]
20. CCL27-CCR10 and CXCL12-CXCR4 chemokine ligand-receptor mRNA expression ratio: new predictive factors of tumor progression in cutaneous malignant melanoma.
Monteagudo C; Ramos D; Pellín-Carcelén A; Gil R; Callaghan RC; Martín JM; Alonso V; Murgui A; Navarro L; Calabuig S; López-Guerrero JA; Jordá E; Pellín A
Clin Exp Metastasis; 2012 Aug; 29(6):625-37. PubMed ID: 22526457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
